The economic burden of depression in the United States: how did it change between 1990 and 2000?
about
Fluvoxamine versus other anti-depressive agents for depressionMilnacipran versus other antidepressive agents for depressionEffectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?A phase III, double-blind, placebo-controlled, flexible-dose study of levomilnacipran extended-release in patients with major depressive disorderProteomic investigation of epigenetics in neuropsychiatric disorders: a missing link between genetics and behavior?The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey ReplicationCognitive remission: a novel objective for the treatment of major depression?Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysisChallenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved TherapeuticsThe effectiveness of return-to-work interventions that incorporate work-focused problem-solving skills for workers with sickness absences related to mental disorders: a systematic literature reviewLate life depression: a global problem with few resourcesPupillary motility: bringing neuroscience to the psychiatry clinic of the futureNeuromodulation for mood and memory: from the engineering bench to the patient bedsideA brief history of the development of antidepressant drugs: from monoamines to glutamateIncreased Signaling via Adenosine A1 Receptors, Sleep Deprivation, Imipramine, and Ketamine Inhibit Depressive-like Behavior via Induction of Homer1a.The depression treatment cascade in primary care: a public health perspective.Men, Work, and Mental Health: A Systematic Review of Depression in Male-dominated Industries and OccupationsVilazodone for the treatment of major depressive disorder: an evidence-based review of its place in therapyGenome-wide linkage on chromosome 10q26 for a dimensional scale of major depressionDepression and heart rate variability in firefightersAntidepressant treatment outcome depends on the quality of the living environment: a pre-clinical investigation in miceCharacterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims databaseBilateral epidural prefrontal cortical stimulation for treatment-resistant depressionAcceptance and commitment therapy and behavioral activation for the treatment of depression: description and comparisonThe role of vitamin D in the prevention of late-life depression.Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment.Resting frontal EEG asymmetry as an endophenotype for depression risk: sex-specific patterns of frontal brain asymmetry.Depressed mood enhances anxiety to unpredictable threat.Mood-linked responses in medial prefrontal cortex predict relapse in patients with recurrent unipolar depressionRepeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats.Implementing measurement-based care (iMBC) for depression in community mental health: a dynamic cluster randomized trial study protocol.Systematic review and assessment of validated case definitions for depression in administrative dataA new clinical rating scale for work absence and productivity: validation in patients with major depressive disorderMissing clinical and behavioral health data in a large electronic health record (EHR) systemAnalysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data.Rasch model analysis of the Depression, Anxiety and Stress Scales (DASS).Effectiveness and cost-effectiveness of an exposure-based return-to-work programme for patients on sick leave due to common mental disorders: design of a cluster-randomized controlled trial.Using a smartphone app to reduce cognitive vulnerability and mild depressive symptoms: Study protocol of an exploratory randomized controlled trial.Parent Depression and Child Anxiety: An Overview of the Literature with Clinical ImplicationsAntidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models
P2860
Q24236814-73692E0C-9280-457D-88AC-CEF49A42E590Q24240125-3C37CC32-5693-43B7-A6D9-BC5D2DB13209Q24288917-7D2DE761-684F-4152-A969-62FF2598DFE9Q24564427-55D664E6-122A-4149-BE2C-3AAD5A4E8BEBQ24603107-08DC78BA-489D-4680-A5FF-B08FE543603EQ24632666-CA372CBA-E2D3-46FC-BB3C-73456F91CC69Q26775386-A82F1FEB-78ED-495C-8430-8F789F0CE56EQ26779632-4CFB5FE4-4A82-4DB3-AE31-3E66A32A8C47Q26782997-58419923-7D62-4AC0-BCBF-609104D9B936Q26827659-BC7A5C88-7FED-4D1A-AD00-DDA26A0D48FDQ26995710-610AD57B-DAC5-4B6D-BFB3-F15E5344C2D3Q27014852-C7DCFA08-0809-47CE-AAAE-A6B9CD0105F0Q27023810-3342D375-F9A7-4125-83F3-FE3F078EB9BCQ27028050-638BD54E-FCE8-479D-9DBA-F3AD0B36388BQ27305254-89060AA1-86D3-494F-9C60-24D006CA5193Q27692061-F5E7C628-3881-45BB-91A8-F09D45956911Q28073097-4405E898-D406-4DC3-B471-7A502FAEA36FQ28083651-99286BB8-7E99-4A9E-B48D-160D1324AC88Q28384381-3BA26EF7-3844-443E-B64C-7973671E3491Q28391244-80D3B16F-40C7-4F3F-AFA7-73E884DF14D7Q28487260-C4D8ADBC-A165-461A-879B-19AE6A76B7DAQ28534539-F36873CA-F52D-4289-BEFF-5F3B41782F74Q28752373-38EB751C-69CB-4652-9750-AFF6DFD50E14Q28758771-E7F1FFF3-8B75-40C4-888C-DD5E5191CBA9Q30251744-C8651615-7DAC-428D-B864-4A2B830777E7Q30372214-D51E053D-74C1-4901-8DC2-8BC3E784E4CCQ30431266-1CEE2A9D-0BA2-4157-BA2E-CFE8B7895C97Q30466260-D6960518-099B-48A6-A4D9-69A3A2C70D12Q30502895-071A13F7-B39C-4580-97A1-97BF5692EBC0Q30547324-432D45B2-491A-4BC6-B80E-BE99C7D36129Q30663882-68D07848-24F8-44F3-856F-AD2B2C1B618AQ30861280-CAD00139-EE8D-47E6-9F98-3E0B26523815Q30951773-8DD3DB84-F009-493D-AF63-C1DFD4F4409DQ31077469-A398CB53-731D-4270-8372-FA851BA33054Q31141332-C3282DB2-F7FE-470A-ABFA-0671834CAE0BQ33441923-0913B2E9-4C24-47DE-880D-A46C1815E247Q33445389-93DF9698-167B-48B3-88B2-7A937459BEB1Q33452067-ED2F429A-2808-4BC6-9F23-226D828B7472Q33551755-B6EE3DE7-D1CE-4133-8A8A-C4071B2B6338Q33557520-2616AB5A-1254-4D2B-B999-9EA295C591B8
P2860
The economic burden of depression in the United States: how did it change between 1990 and 2000?
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The economic burden of depress ...... change between 1990 and 2000?
@en
type
label
The economic burden of depress ...... change between 1990 and 2000?
@en
prefLabel
The economic burden of depress ...... change between 1990 and 2000?
@en
P2093
P1476
The economic burden of depress ...... change between 1990 and 2000?
@en
P2093
Howard G Birnbaum
Patricia A Berglund
Patricia K Corey-Lisle
Paul E Greenberg
Sarah W Lowe
Stephanie A Leong
P304
P577
2003-12-01T00:00:00Z